FR2814463B1 - Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine - Google Patents

Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Info

Publication number
FR2814463B1
FR2814463B1 FR0012094A FR0012094A FR2814463B1 FR 2814463 B1 FR2814463 B1 FR 2814463B1 FR 0012094 A FR0012094 A FR 0012094A FR 0012094 A FR0012094 A FR 0012094A FR 2814463 B1 FR2814463 B1 FR 2814463B1
Authority
FR
France
Prior art keywords
biotine
biotin
derivative
covalent binding
antithrombotic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0012094A
Other languages
English (en)
French (fr)
Other versions
FR2814463A1 (fr
Inventor
Philippe Duchaussoy
Jean Marc Herbert
Maurice Petitou
Pierre Savi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to FR0012094A priority Critical patent/FR2814463B1/fr
Priority to PL363368A priority patent/PL206727B1/pl
Priority to EA200300237A priority patent/EA005133B1/ru
Priority to NZ524472A priority patent/NZ524472A/en
Priority to HK03105615.1A priority patent/HK1053316B/xx
Priority to DE60130669T priority patent/DE60130669T2/de
Priority to HR20030219A priority patent/HRP20030219B1/xx
Priority to HU0303551A priority patent/HUP0303551A3/hu
Priority to PT01972171T priority patent/PT1322673E/pt
Priority to CZ20030814A priority patent/CZ300856B6/cs
Priority to GE5103A priority patent/GEP20053616B/en
Priority to KR1020037004108A priority patent/KR100891388B1/ko
Priority to SK356-2003A priority patent/SK287054B6/sk
Priority to MEP-2008-236A priority patent/ME00080B/me
Priority to US10/381,154 priority patent/US6844329B2/en
Priority to SI200130786T priority patent/SI1322673T1/sl
Priority to EP01972171A priority patent/EP1322673B1/fr
Priority to MEP-236/08A priority patent/MEP23608A/xx
Priority to CNB018161588A priority patent/CN1235914C/zh
Priority to EEP200300114A priority patent/EE05202B1/xx
Priority to DK01972171T priority patent/DK1322673T3/da
Priority to IL15484801A priority patent/IL154848A0/xx
Priority to JP2002529162A priority patent/JP5016778B2/ja
Priority to UA2003021719A priority patent/UA79736C2/uk
Priority to MXPA03002483A priority patent/MXPA03002483A/es
Priority to KR1020087009747A priority patent/KR20080049139A/ko
Priority to AU9196001A priority patent/AU9196001A/xx
Priority to PCT/FR2001/002918 priority patent/WO2002024754A1/fr
Priority to AT01972171T priority patent/ATE374215T1/de
Priority to ARP010104436A priority patent/AR030774A1/es
Priority to YUP-197/03A priority patent/RS50730B/sr
Priority to SK5031-2009A priority patent/SK287218B6/sk
Priority to AU2001291960A priority patent/AU2001291960C1/en
Priority to ES01972171T priority patent/ES2292625T3/es
Priority to HUP1400034 priority patent/HU1400034D0/hu
Priority to CA2418815A priority patent/CA2418815C/en
Priority to BR0114007-8A priority patent/BR0114007A/pt
Priority to PE2001000952A priority patent/PE20020471A1/es
Priority to TW090123340A priority patent/TWI308153B/zh
Publication of FR2814463A1 publication Critical patent/FR2814463A1/fr
Application granted granted Critical
Publication of FR2814463B1 publication Critical patent/FR2814463B1/fr
Priority to IS6733A priority patent/IS2550B/is
Priority to ZA200301692A priority patent/ZA200301692B/en
Priority to IL154848A priority patent/IL154848A/en
Priority to EC2003004514A priority patent/ECSP034514A/es
Priority to NO20031295A priority patent/NO332905B1/no
Priority to BG107650A priority patent/BG66191B1/bg
Priority to US11/035,717 priority patent/US7943595B2/en
Priority to CY20071101542T priority patent/CY1108076T1/el
Priority to US13/036,143 priority patent/US8318696B2/en
Priority to NO20110401A priority patent/NO20110401L/no
Priority to JP2012027377A priority patent/JP2012131809A/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR0012094A 2000-09-22 2000-09-22 Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine Expired - Fee Related FR2814463B1 (fr)

Priority Applications (50)

Application Number Priority Date Filing Date Title
FR0012094A FR2814463B1 (fr) 2000-09-22 2000-09-22 Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
PL363368A PL206727B1 (pl) 2000-09-22 2001-09-20 Syntetyczne polisacharydy o działaniu przeciwzakrzepowym, zawierające je środki farmaceutyczne, zastosowanie tych środków i zastosowanie tych polisacharydów oraz awidyny lub streptoawidyny
EA200300237A EA005133B1 (ru) 2000-09-22 2001-09-20 Полисахариды с антитромботической активностью, содержащие по меньшей мере одну ковалентную связь с биотином или производным биотина
NZ524472A NZ524472A (en) 2000-09-22 2001-09-20 Compounds comprising oligosaccharides bound covalently to biotin or a biotin derivative with prohaemorrhagic activity that is neutralised rapidly by injection with avidin or streptavidin
HK03105615.1A HK1053316B (en) 2000-09-22 2001-09-20 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
DE60130669T DE60130669T2 (de) 2000-09-22 2001-09-20 Polysaccharide mit antithrombotischer wirkung, die mit biotin oder einem biotinderivat kovalent gebunden sind
HR20030219A HRP20030219B1 (hr) 2000-09-22 2001-09-20 Polisaharidi s antitromboznom aktivnošću koji sadrže bar jednu kovalentnu vezu s biotinom ili biotinskim derivatom
HU0303551A HUP0303551A3 (en) 2000-09-22 2001-09-20 Polysaccharides with antithromotic activity comprising at least a covalent bond with biotin or a biotin derivative and pharmaceutical compositions containing them
PT01972171T PT1322673E (pt) 2000-09-22 2001-09-20 Polissacáridos com actividade antitrombótica compreendendo, pelo menos, uma ligação covalente com a biotina ou com um derivado da biotina
CZ20030814A CZ300856B6 (cs) 2000-09-22 2001-09-20 Polysacharidy s antitrombotickou aktivitou obsahující alespon jednu kovalentní vazbu s biotinem nebo derivátem biotinu a jejich použití pro výrobu léciva
GE5103A GEP20053616B (en) 2000-09-22 2001-09-20 Polysaccharides with Antithrombotic Activity Comprising At Least one Covalent Bond with Biotin or Biotin Derivative
KR1020037004108A KR100891388B1 (ko) 2000-09-22 2001-09-20 바이오틴 또는 바이오틴 유도체와의 1 이상의 공유 결합을포함하는 항혈전 활성이 있는 다당류
SK356-2003A SK287054B6 (sk) 2000-09-22 2001-09-20 Polysacharidy s antitrombotickou aktivitou obsahujúce aspoň jednu kovalentnú väzbu s biotínom alebo derivátom biotínu a ich použitie pri liečení
MEP-2008-236A ME00080B (me) 2000-09-22 2001-09-20 Polisaharidi sa antitrombičkom aktivnošću koji sadrže najmanje jednu kovalentnu vezu sa biotinom ili derivatom biotina
US10/381,154 US6844329B2 (en) 2000-09-22 2001-09-20 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
SI200130786T SI1322673T1 (sl) 2000-09-22 2001-09-20 Polisaharidi z antitromboticno aktivnostjo, ki obsegajo vsaj eno kovalentno vez z biotinom ali derivatom biotina
EP01972171A EP1322673B1 (fr) 2000-09-22 2001-09-20 Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
MEP-236/08A MEP23608A (bs) 2000-09-22 2001-09-20 Polisaharidi sa antritrombičkom aktivnošću koji sadrže najmanje jednu kovalentnu vezu sa biotinom ili derivatom biotina
CNB018161588A CN1235914C (zh) 2000-09-22 2001-09-20 含有至少一个具有生物素或生物素衍生物共价键的具有抗血栓形成活性的多糖
EEP200300114A EE05202B1 (et) 2000-09-22 2001-09-20 Antitrombootilise toimega polüsahhariidid, millel on vähemalt üks kovalentne side biotiini v?i biotiini derivaadiga
DK01972171T DK1322673T3 (da) 2000-09-22 2001-09-20 Polysaccharider med antithrombotisk aktivitet, der omfatter mindst en kovalent binding til biotin eller et biotinderivat
IL15484801A IL154848A0 (en) 2000-09-22 2001-09-20 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
JP2002529162A JP5016778B2 (ja) 2000-09-22 2001-09-20 ビオチンまたはビオチン誘導体との少なくとも一つの共有結合を含み抗血栓活性を有するポリサッカライド
UA2003021719A UA79736C2 (uk) 2000-09-22 2001-09-20 Полісахариди з антитромботичною активністю, що мають ковалентний зв'язок з біотином або похідним біотину
MXPA03002483A MXPA03002483A (es) 2000-09-22 2001-09-20 Polisacaridos con actividad antitrombotica que comprenden al menos un enlace covalente con biotina o un derivado de biotina.
KR1020087009747A KR20080049139A (ko) 2000-09-22 2001-09-20 바이오틴 또는 바이오틴 유도체와의 1 이상의 공유 결합을포함하는 항혈전 활성이 있는 다당류
AU9196001A AU9196001A (en) 2000-09-22 2001-09-20 Polysaccharides with antithrombotic activity comprising at least a covalent bondwith biotin or a biotin derivative
PCT/FR2001/002918 WO2002024754A1 (fr) 2000-09-22 2001-09-20 Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
AT01972171T ATE374215T1 (de) 2000-09-22 2001-09-20 Polysaccharide mit antithrombotischer wirkung, die mit biotin oder einem biotenderivat kovalent gebunden sind
ARP010104436A AR030774A1 (es) 2000-09-22 2001-09-20 Nuevos polisacaridos de actividad antitrombotica que presentan por lo menos un enlace covalente con la biotina o un derivado de la biotina
YUP-197/03A RS50730B (sr) 2000-09-22 2001-09-20 Polisaharidi sa antitrombičkom aktivnošću koji sadrže najmanje jednu kovalentnu vezu sa biotinom ili derivatom biotina
SK5031-2009A SK287218B6 (sk) 2000-09-22 2001-09-20 Použitie avidínu alebo streptavidínu na prípravu liečiv na neutralizáciu antitrombotickej aktivity syntetických polysacharidov
AU2001291960A AU2001291960C1 (en) 2000-09-22 2001-09-20 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
ES01972171T ES2292625T3 (es) 2000-09-22 2001-09-20 Polisacaridos con actividad antitrombotica que comprenden al menos un enlace covalente con la biotina o un derivado de la biotina.
HUP1400034 HU1400034D0 (hu) 2000-09-22 2001-09-20 Biotin vagy biotin származékok és antitrombotikus hatású poliszacharidok között legalább egy kovalens kötést tartalmazó vegyületek által kiváltott vérzések kezelése
CA2418815A CA2418815C (en) 2000-09-22 2001-09-20 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
BR0114007-8A BR0114007A (pt) 2000-09-22 2001-09-20 Polissacarìdeos de atividade antitrombótica, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina
PE2001000952A PE20020471A1 (es) 2000-09-22 2001-09-21 Nuevos polisacaridos de actividad antitrombotica que presentan por lo menos un enlace covalente con la biotina o un derivado de la biotina
TW090123340A TWI308153B (en) 2000-09-22 2001-09-21 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
IS6733A IS2550B (is) 2000-09-22 2003-02-28 Fjölsykrur með virkni gegn blóðtappa, sem samanstanda af, að minnsta kosti, samgildu tengi við bíótín eða bíótínafleiðu
ZA200301692A ZA200301692B (en) 2000-09-22 2003-02-28 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative.
IL154848A IL154848A (en) 2000-09-22 2003-03-10 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
EC2003004514A ECSP034514A (es) 2000-09-22 2003-03-14 Nuevos polisacaridos de actividad antitrombotica que presentan por lo menos un enlace covalente con la biotina o un derivado de la biotina
NO20031295A NO332905B1 (no) 2000-09-22 2003-03-20 Syntetiske polysakkarider med antitrombotisk aktivitet inneholdende minst en kovalent binding med biotin eller et biotinderivat, anvendelse derav og farmasoytiske preparater omfattende slike polysakkarider.
BG107650A BG66191B1 (bg) 2000-09-22 2003-03-20 Полизахариди с антитромболитична активност, които съдържат поне една ковалентна връзка с биотин или производно на биотин
US11/035,717 US7943595B2 (en) 2000-09-22 2005-01-14 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
CY20071101542T CY1108076T1 (el) 2000-09-22 2007-12-04 Πολυσακχαριτες με αντιθρομβωτικη δραση που περιεχουν τουλαχιστον εναν ομοιοπολικο δεσμο με τη βιοτινη ή ενα παραγωγο της βιοτινης
US13/036,143 US8318696B2 (en) 2000-09-22 2011-02-28 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
NO20110401A NO20110401L (no) 2000-09-22 2011-03-16 Polysakkarider med antitrombotisk aktivitet inneholder minst en kovalentbinding med biotin eller et biotinderivat
JP2012027377A JP2012131809A (ja) 2000-09-22 2012-02-10 ビオチンまたはビオチン誘導体との少なくとも一つの共有結合を含み抗血栓活性を有するポリサッカライド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0012094A FR2814463B1 (fr) 2000-09-22 2000-09-22 Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Publications (2)

Publication Number Publication Date
FR2814463A1 FR2814463A1 (fr) 2002-03-29
FR2814463B1 true FR2814463B1 (fr) 2002-11-15

Family

ID=8854579

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0012094A Expired - Fee Related FR2814463B1 (fr) 2000-09-22 2000-09-22 Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Country Status (39)

Country Link
US (3) US6844329B2 (enExample)
EP (1) EP1322673B1 (enExample)
JP (2) JP5016778B2 (enExample)
KR (2) KR20080049139A (enExample)
CN (1) CN1235914C (enExample)
AR (1) AR030774A1 (enExample)
AT (1) ATE374215T1 (enExample)
AU (2) AU2001291960C1 (enExample)
BG (1) BG66191B1 (enExample)
BR (1) BR0114007A (enExample)
CA (1) CA2418815C (enExample)
CY (1) CY1108076T1 (enExample)
CZ (1) CZ300856B6 (enExample)
DE (1) DE60130669T2 (enExample)
DK (1) DK1322673T3 (enExample)
EA (1) EA005133B1 (enExample)
EC (1) ECSP034514A (enExample)
EE (1) EE05202B1 (enExample)
ES (1) ES2292625T3 (enExample)
FR (1) FR2814463B1 (enExample)
GE (1) GEP20053616B (enExample)
HR (1) HRP20030219B1 (enExample)
HU (2) HUP0303551A3 (enExample)
IL (2) IL154848A0 (enExample)
IS (1) IS2550B (enExample)
ME (2) ME00080B (enExample)
MX (1) MXPA03002483A (enExample)
NO (2) NO332905B1 (enExample)
NZ (1) NZ524472A (enExample)
PE (1) PE20020471A1 (enExample)
PL (1) PL206727B1 (enExample)
PT (1) PT1322673E (enExample)
RS (1) RS50730B (enExample)
SI (1) SI1322673T1 (enExample)
SK (2) SK287218B6 (enExample)
TW (1) TWI308153B (enExample)
UA (1) UA79736C2 (enExample)
WO (1) WO2002024754A1 (enExample)
ZA (1) ZA200301692B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
CN101312747B (zh) * 2005-10-10 2013-03-20 Msd欧斯股份有限公司 包括生物素标记的抗血栓形成双重抑制剂
MY145269A (en) * 2005-10-10 2012-01-13 Organon Nv Antithrombotic dual inhibitors comprising a biotin label
CN1317035C (zh) * 2005-10-24 2007-05-23 天津大学 基于酰肼基的微粒表面多重生物功能因子组装方法
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
EP2145624A1 (en) 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
CA2735983A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
MX362853B (es) 2008-12-19 2019-02-20 Supernus Pharmaceuticals Inc Uso de molindona para el tratamiento de agresión.
FR2952935B1 (fr) * 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle
WO2011073408A2 (en) 2009-12-18 2011-06-23 Endotis Pharma Pharmaceutical oral dosage form containing a synthetic oligosaccharide
CZ302510B6 (cs) * 2010-03-29 2011-06-22 Univerzita Palackého v Olomouci Efektivní zpusob biotinylace sloucenin s karboxylovou skupinou pomocí syntézy na pevné fázi pro potreby afinitní chromatografie
CZ302669B6 (cs) * 2010-03-29 2011-08-24 Univerzita Palackého v Olomouci Efektivní zpusob biotinylace aminosloucenin pomocí syntézy na pevné fázi pro potreby afinitní chromatografie
EP3572074B1 (en) 2010-03-31 2021-01-06 Supernus Pharmaceuticals, Inc. Stabilized formulations of molindone
FR2964660B1 (fr) * 2010-09-10 2012-09-28 Sanofi Aventis Nouveaux polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
JP2013537181A (ja) * 2010-09-10 2013-09-30 サノフイ 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類
EP2484366A1 (en) 2011-02-07 2012-08-08 Sanofi Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events
US9556215B2 (en) 2011-06-17 2017-01-31 Carbomimetics Synthetic pentasaccharides having short half-life and high activity
AU2013344920A1 (en) * 2012-11-13 2015-04-30 Supernus Pharmaceuticals, Inc. Method of treatment of aggression
WO2015195404A1 (en) 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en) 2015-06-15 2016-12-22 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
CN110234600B (zh) 2016-10-21 2023-03-21 美国政府(由卫生和人类服务部的部长所代表) 分子纳米标签
CN108976318B (zh) * 2017-06-01 2021-03-30 首都医科大学 单-6-(生物素酰胺基)-6-脱氧-β-环糊精及其制备方法和应用
WO2019133727A1 (en) 2017-12-29 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Universal influenza virus probe set for enrichment of any influenza virus nucleic acid
CN114616340A (zh) 2019-07-09 2022-06-10 奥普蒂姆维亚有限公司 合成抗凝血多糖的方法
WO2021075165A1 (ja) * 2019-10-17 2021-04-22 株式会社オートネットワーク技術研究所 配線モジュール
WO2022056078A1 (en) 2020-09-11 2022-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rnase h-assisted detection assay for rna (radar)
WO2024191684A1 (en) 2023-03-10 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960884A (en) * 1974-04-24 1976-06-01 Sergei Ivanovich Zavyalov Method of preparing racemic biotin
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
WO2000002050A1 (en) * 1998-07-07 2000-01-13 Department Of Radiation Oncology, University Of Washington Trifunctional reagent for conjugation to a biomolecule
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) * 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
GB2335490B (en) * 1998-03-20 2003-05-14 Ortho Clinical Diagnostics An assay surface that permits an analyte releasiing step
KR20010030803A (ko) 1998-07-31 2001-04-16 야마야 와따루 신규 글리코사미노글리칸 및 이를 함유하는 의약 조성물
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
NO20031295L (no) 2003-05-22
AU2001291960C1 (en) 2009-10-08
EE05202B1 (et) 2009-08-17
SI1322673T1 (sl) 2008-02-29
DK1322673T3 (da) 2008-01-14
BR0114007A (pt) 2003-08-12
ME00080B (me) 2010-10-10
SK287218B6 (sk) 2010-03-08
WO2002024754A8 (fr) 2003-07-03
NO20031295D0 (no) 2003-03-20
CA2418815C (en) 2011-05-10
US6844329B2 (en) 2005-01-18
IL154848A0 (en) 2003-10-31
HU1400034D0 (hu) 2004-03-01
WO2002024754A1 (fr) 2002-03-28
IS2550B (is) 2009-10-15
MEP23608A (bs) 2010-06-10
JP5016778B2 (ja) 2012-09-05
BG66191B1 (bg) 2011-12-30
US20040024197A1 (en) 2004-02-05
NO20110401L (no) 2003-05-22
EA200300237A1 (ru) 2003-08-28
CA2418815A1 (en) 2002-03-28
IS6733A (is) 2003-02-28
SK287054B6 (sk) 2009-10-07
ECSP034514A (es) 2003-04-25
ATE374215T1 (de) 2007-10-15
MXPA03002483A (es) 2004-05-24
NO332905B1 (no) 2013-01-28
ZA200301692B (en) 2004-03-01
EE200300114A (et) 2005-02-15
IL154848A (en) 2010-11-30
YU19703A (sh) 2006-05-25
PE20020471A1 (es) 2002-06-01
CN1466594A (zh) 2004-01-07
BG107650A (bg) 2003-11-28
US20110144042A1 (en) 2011-06-16
AU2001291960B2 (en) 2007-03-01
US20060160768A1 (en) 2006-07-20
EA005133B1 (ru) 2004-12-30
CN1235914C (zh) 2006-01-11
KR100891388B1 (ko) 2009-04-02
EP1322673B1 (fr) 2007-09-26
NZ524472A (en) 2004-10-29
RS50730B (sr) 2010-08-31
US7943595B2 (en) 2011-05-17
PL206727B1 (pl) 2010-09-30
AU9196001A (en) 2002-04-02
ES2292625T3 (es) 2008-03-16
HUP0303551A3 (en) 2004-03-29
JP2012131809A (ja) 2012-07-12
CZ2003814A3 (cs) 2003-06-18
AR030774A1 (es) 2003-09-03
JP2004509902A (ja) 2004-04-02
EP1322673A1 (fr) 2003-07-02
HK1053316A1 (zh) 2003-10-17
CZ300856B6 (cs) 2009-08-26
UA79736C2 (uk) 2007-07-25
HUP0303551A2 (hu) 2004-03-01
KR20030055269A (ko) 2003-07-02
PT1322673E (pt) 2007-12-03
US8318696B2 (en) 2012-11-27
DE60130669D1 (de) 2007-11-08
CY1108076T1 (el) 2014-02-12
HRP20030219B1 (hr) 2011-10-31
HRP20030219A2 (en) 2003-06-30
DE60130669T2 (de) 2008-07-17
FR2814463A1 (fr) 2002-03-29
KR20080049139A (ko) 2008-06-03
SK3562003A3 (en) 2003-11-04
TWI308153B (en) 2009-04-01
GEP20053616B (en) 2005-09-26
PL363368A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
FR2814463B1 (fr) Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
AU2001291960A1 (en) Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
PT1164870E (pt) Barra de cereais
DE122004000018I1 (de) 4"-Substitutierte-9-Deoxo-9A-Aza-9A-Homoerythromycin a Derivate.
DE69815396D1 (de) Zum binden von zellulose befähigtes polysaccharid-konjugat
NO996107L (no) C-4"-substituerte makrolidderivater
DE59704394D1 (de) Pendelnd gelagerte, gefederte achsaufhängung
NL1018597A1 (nl) Schakelketting.
FR2767877B1 (fr) Liaison d'arbres
NO990859L (no) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridinderivater
EP0910669A4 (en) ISOLATED NUCLEIC ACID MOLECULES, WHICH ARE MEMBERS OF THE MAGE B FAMILY, AND THEIR APPLICATIONS
FR2763851B1 (fr) Compositions comprenant un derive de dibenzoylmethane et un polymere polyamine
ITGE980021A0 (it) Corpetto equilibratore attrezzato.
FR2790344B1 (fr) Demodulateur cofdm avec compensation de deplacement de fenetre d'analyse fft
ITTO980664A0 (it) Catena di cerniera lampo.
DE69809966D1 (de) Anordnung zum gewichtsausgleich
KR970001346A (ko) 3--s- 트리아진-2,4,6-옥소 또는 티오트리온 제초제
FR2761273B3 (fr) Planche de glisse
FR2780375B1 (fr) Tondeuse ou machine analogue a guidon articule
IL147893A0 (en) Enzymes with beta-(1, 6)-endoglucanase activity
FR2804182B1 (fr) Clavette de liaison de deux pieces
BR9810558B1 (pt) composição quìmica agrìcola em suspensão aquosa.
ES1031515Y (es) Colgador modular polivalente.
ES1044049Y (es) Rifle virtual de entrenamiento.
FR2730622B1 (fr) Brasero a volaille ou gibier

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20170531